1.
Unexpected and persistent depletion of B lymphocytes CD20 following a minimum dose of anti-CD20 antibody (Rituximab). Reumatismo [Internet]. 2009 Sep. 30 [cited 2025 Jun. 6];61(4):306-8. Available from: https://www.reumatismo.org/reuma/article/view/reumatismo.2009.306